Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the risk/benefit profile of a 5% minoxidil topical foam (MTF) formulation applied OD for the treatment of female pattern hair loss FPHL) in comparison to 2% minoxidil topical solution (MTS) formulation used BID, using objective efficacy measures and safety assessments.
Critère d'inclusion
- FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA)